English  |  正體中文  |  简体中文  |  Items with full text/Total items : 54367/62174 (87%)
Visitors : 14960104      Online Users : 40
RC Version 6.0 © Powered By DSPACE, MIT. Enhanced by NTHU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    National Tsing Hua University Institutional Repository > 生命科學院  > 生命科學系 > 期刊論文 >  Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model

    Please use this identifier to cite or link to this item: http://nthur.lib.nthu.edu.tw/dspace/handle/987654321/48996

    Title: Accumulated immune complexes of IgE and omalizumab trap allergens in an in vitro model
    Authors: Chuan-Long Hsu;Yu-Yu Shiung;Bai-Ling Lin;Hwan-You Chang;Tse Wen Chang
    教師: 張晃猷
    Date: 2010
    Publisher: Elsevier
    Relation: International Immunopharmacology,Elsevier,Volume 10,Issue 4,April 2010,Pages 533-539
    Keywords: Anti-IgE
    Allergen trapping
    In vitro reconstitution
    Abstract: The best understood mechanisms of omalizumab are that it neutralizes free IgE and down-regulates high-affinity IgE.Fc receptors (FcεRI) on basophils and mast cells. It has been proposed that since complexes of IgE and omalizumab are accumulated to 5–10 times the basal levels of IgE, they may trap incoming allergens, contributing to omalizumab's effectiveness. In order to investigate the ability of IgE:omalizumab complexes in trapping allergens and inhibiting basophil activation in an in vitro reconstitution model, the ability of IgE:omalizumab complexes to tie up antigen and hence inhibit (a) antigen binding to IgE bound by FcεRI, and (b) antigen-mediated activation of basophils, was examined. The free IgE was prepared by mixing different proportions of antigen-nonspecific IgE secreted by U266 cells and antigen-specific IgE, SE44 IgE, which recognizes a synthetic 15 a.a. peptide, R15K. The antigen was (R15K)8-ova, i.e. ovalbumin conjugated with an average of 8 copies of R15K per molecule. The solid-phase FcεRI was a recombinant protein representing the extracellular portion of the α chain of the FcεRI receptor complex. The model FcεRI+ basophilic cell line was RBL.SX-38, a rat basophilic leukemic line transfected with the genes for α, β and γ subunits of human FcεRI. The results showed that the IgE:omalizumab complexes trapped increasing amounts of antigen with increasing (a) concentration of IgE, (b) proportion of antigen-specific IgE in total IgE, and (c) concentration of total immune complexes. Such trapping decreased the antigen-induced activation of FcεRI+ cells that had been pulsed with antigen-specific IgE, resulting in decreased mediator release. These results suggest that the rapidly accumulated IgE:omalizumab complexes in omalizumab-treated patients can capture allergens and consequently contribute to the pharmacological effects of omalizumab.
    URI: http://www.elsevier.com/
    Appears in Collections:[生命科學系] 期刊論文

    Files in This Item:

    File Description SizeFormat


    SFX Query


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback